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Rinderpest virus, like other Morbilliviruses, expresses three proteins from the single P gene. In addition to the P protein,
which interacts both with the viral polymerase (L) and the nucleocapsid (N) protein, the virus expresses a C and a V protein
from the same gene. The functions of these two proteins in the viral life cycle are not clear. Although both C and V proteins
are dispensable, in that viable viruses can be made that express neither, each seems to play a role in optimum viral
replication. We have used the yeast-two hybrid system, binding to coexpressed fusions of C and V to glutathione-S-
transferase, and studies of the native size of these proteins to investigate interactions of the rinderpest virus C and V proteins
with other virus-encoded proteins. The V protein was found to interact with both the N and L proteins, while the C protein
was found to bind to the L protein, and to self-associate in high-molecular-weight aggregates. © 2001 Academic Press
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Rinderpest is a devastating disease of large rumi-
nants, primarily infecting domestic cattle (resulting in
substantial economic losses), but also affecting wildlife
such as buffalo, kudu, giraffe, wildebeest, and antelope.
The causative agent of this important disease is Rinder-
pest virus (RPV). RPV is a negative-stranded ssRNA virus
within the genus Morbillivirus and family Paramyxoviri-
ae of the order Mononegavirales. RPV is therefore
closely related to a human pathogen, Measles virus
(MeV); other members of the genus include Peste des
petits ruminants virus (PPRV), Canine distemper virus
(CDV), Phocid distemper virus (PDV), and the more re-
cently isolated cetacean morbilliviruses, Dolphin and
Porpoise morbilliviruses. The RPV genome is composed
of 15,882 bases (Baron et al., 1996) and encodes six
genes (39-N-P-M-F-H-L 59 gene order along the genome)
coding for the nucleocapsid protein (N), the phosphopro-
tein (P), the matrix protein (M), the fusion protein (F), the
hemagglutinin protein (H), and the large protein (L), or
polymerase.
The Paramyxoviridae P genes share a common strat-
egy of genomic economy; through the utilisation of alter-
native open reading frames (ORFs) within the gene, they
have the ability to produce additional proteins. All the
Paramyxovirinae P genes, with the exception of Human
parainfluenza virus type 1 (hPIV1) (Matsuoka et al., 1991)
and possibly Human parainfluenza virus type 3 (hPIV3)1 To whom reprint requests should be addressed. Fax: INT144
0)1483 232448. E-mail: michael.baron@bbsrc.ac.uk.
193(Galinski et al., 1992), show a form of co-transcriptional
mRNA editing by a proposed stuttering mechanism
(Thomas et al., 1988; Vidal et al., 1990) that is a function
of the viral-encoded RNA polymerase; non-templated
base insertion into the nascent mRNA introduces a
frameshift of the 39 end of the transcript, resulting in the
production of a protein with an alternate carboxyl termi-
nus. The faithful mRNA transcripts of the Respirovirus
and Morbillivirus P genes code for the P protein, while a
single non-templated base insertion at the editing site
produces a mRNA coding for the V protein. In contrast,
the Rubulavirus faithful P gene transcripts code for the V
protein whilst polymerase insertion of two non-templated
bases is required to produce a P mRNA. In all cases,
viral V proteins consist of the amino terminal half of the
P protein fused to a short cysteine-rich domain, which is
highly conserved between all Paramyxovirinae and
which has sequence similarity to the zinc finger motif
found in a number of protein families (reviewed in
O’Halloran, 1993).
The Respirovirus and Morbillivirus P genes also con-
tain, at the 39 end of the gene (59 end of the mRNA), an
alternative ORF coding for a C protein (Shioda et al.,
1983; Barrett et al., 1985; Bellini et al., 1985; Galinski et
al., 1986; Matsuoka et al., 1991; Curran and Rima, 1992;
Yamanaka et al., 1992; Bolt et al., 1995). Rubulaviruses do
not express this protein. The Respirovirus and Morbilli-
virus C protein ORFs are contained within the 59 end of
both P- and V-type mRNAs. The Morbillivirus C protein
ORF is accessed from a single optimal AUG initiation
codon 20 bases downstream of the sub-optimal P/V
AUG, whereas the Respirovirus C protein ORF overlaps
0042-6822/01 $35.00
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194 SWEETMAN, MISKIN, AND BARONthe P/V ORF and is accessed by two to four different
initiation codons [the first of which is GUG (hPIV1, Boeck
et al., 1992) or ACG (Sendai virus, SeV, Curran and Ko-
lakofsky, 1988; Gupta and Patwardhan, 1988), rather than
the normal AUG], giving rise to a nested set of C proteins:
C9, C, Y1, and Y2 (Curran and Kolakofsky, 1988, 1989;
Gupta and Patwardhan, 1988; Boeck et al., 1992). Despite
he similar coding strategies for the Respirovirus and
orbillivirus C proteins, there are no significant se-
uence similarities between the C proteins of the two
enera (Baron et al., 1993).
The precise functions of the Paramyxovirinae C and V
roteins remain to be determined. They are often de-
cribed as non-structural as they have not been shown
o have a particular structural role within virus particles;
owever, in two members of the Rubulavirus genus,
umps virus (MV) and Simian virus 5 (SV5), V protein has
een detected in virions (Thomas et al., 1988; Takeuchi et
l., 1990; Paterson et al., 1995), while the Respirovirus C
protein has been observed in the virions of Sendai virus
(SeV) (Yamada et al., 1990) and hPIV3 (Galinski et al.,
1986). The reported cellular locations of the V and C
proteins differ. SeV C protein was found evenly distrib-
uted in the cytoplasm (Portner et al., 1986) or distributed
like the nucleocapsid protein in the cytoplasm of infected
cells (Yamada et al., 1990); the C protein of MeV was
observed colocalised with the N protein in the cytoplasm
and also in the nucleus (Bellini et al., 1985). In contrast,
V proteins have almost always been reported diffusely
distributed in the cytoplasm of infected cells with only
partial concentration in particulate bodies or the nucleus
(Curran et al., 1991b; Wardrop and Briedis, 1991; Gombart
et al., 1992; Paterson et al., 1995).
A number of protein interactions have been described
for V proteins. V–N interactions have been recorded in
the Respiroviruses (Horikami et al., 1996), Rubulaviruses
(Randall and Bermingham, 1996; Watanabe et al., 1996),
and Morbilliviruses (Tober et al., 1998); such an interac-
tion would be expected since the amino terminus of
several P proteins (the domain common to both P and V)
contains a binding site for the viral N protein (Harty and
Palese, 1995; Horikami et al., 1996; Randall and Berming-
ham, 1996). A further interaction between the V and L
proteins was proposed in SeV (Curran et al., 1991a)
based upon an observed inhibition of replication of a
defective interfering (DI) genome by the V protein and the
assumption that the amino terminus of P bound to L.
However, later studies mapped the SeV P–L interaction
to the carboxyl terminus of P (Smallwood et al., 1994),
which is not present in V. The carboxyl-terminal zinc
finger-like motif of V has been shown to bind zinc by this
domain (Liston and Briedis, 1994; Paterson et al., 1995).
Furthermore, the V proteins of MeV (Liston et al., 1995)
and SV5 (Lin et al., 1998) have been shown to interact
with host cellular proteins, in particular to the damaged
DNA binding protein (Lin et al., 1998), and this interactionwas shown to require the V-specific zinc-binding region.
Recombinant viruses with silenced expression of V have
shown normal growth rates in tissue culture (Delenda et
al., 1997; Kato et al., 1997a; Schneider et al., 1997; Baron
and Barrett, 2000) but reduced pathogenesis in animals
(Kato et al., 1997a; Tober et al., 1998).
In in vitro studies, SeV C protein has been shown
selectively to inhibit the genomic 39 promoter activity
governing antigenome and message transcription (Cur-
ran et al., 1992; Cadd et al., 1996; Tapparel et al., 1997)
and to increase promoter specificity and the requirement
that SeV genomes are an exact multiple of six bases
(Tapparel et al., 1997), the so-called “rule of six” (Calain
and Roux, 1993). These effects appear to be mediated
through a specific interaction with the viral polymerase
(L) (Horikami et al., 1997). Recombinant SeV expressing
either the C9 or C proteins (but not both) grew to similar
titres as wild-type virus with the anticipated elevated
RNA synthesis. However, deleted expression of both C9
and C proteins reduced viral growth (Kurotani et al., 1998;
Latorre et al., 1998). Deleted expression of all four SeV C
proteins results in a virus severely attenuated in tissue
culture; furthermore, a virus with deleted expression of
C9 and C was incapable of productive infection in the
natural host (Kurotani et al., 1998). Much less is known
about the role of the Morbillivirus C protein. It has been
reported not to interact with other viral proteins (Liston et
al., 1995). In recombinant MeV, silenced expression of
the C protein produces a virus that grows normally in cell
culture (Radecke and Billeter, 1996) but not in human
peripheral blood cells (Escoffier et al., 1999). In contrast,
studies using a recombinant RPV that is unable to ex-
press the C protein have shown impaired growth in
culture and reduced mRNA transcription from viral genes
(Baron and Barrett, 2000).
We have further studied the C and V proteins of RPV by
investigating possible interactions between these pro-
teins and components of the viral core to determine
whether they exert their effects directly or indirectly.
RESULTS
Distribution of C and V proteins in viral infected cells
RPV-infected cells were probed using polyclonal anti-
bodies to the L, N, V, and C proteins of RPV; for compar-
ison, all cells were counter-stained with a mouse mono-
clonal antibody that recognises the RPV P protein but not
the V protein. This monoclonal antibody has proven to be
extremely sensitive in detecting RPV infection, enabling
virus to be detected as little as 8 h p.i., earlier than any
other antibody we have (data not shown). Cells in the
fields shown in Figs. 1 (1b, 1d, 1f, and 1g) that are not
stained with this antibody are uninfected. All of our poly-
clonal antisera show a variable amount of background
staining of uninfected cells (Figs. 1a, 1c, 1e, and 1g);
comparison with the staining of the same field with
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195INTERACTIONS OF RINDERPEST VIRUS V AND C PROTEINSmouse anti-P allows internal control of this non-specific
staining. The P protein was found, along with the N
protein, in discrete areas of the infected cell (Figs. 1a and
1b). Although the L protein was hard to visualise, except
late in infection, the L protein that was detectable was
also colocalised with the P protein, in large inclusion
bodies, possibly viral factories (Figs. 1c and 1d). Staining
of the V protein shows a diffuse distribution throughout
the cell, both cytoplasmic and nuclear, with regions of
higher density corresponding to P distribution, particu-
larly at later stages of infection (Figs. 1e and 1f). These
data suggest that the V protein may exist in at least two
populations, one colocalising with P, and therefore with
N and L, and the other distributed throughout the cell.
This is similar to the observations on the V proteins of
MeV (Wardrop and Briedis, 1991) and SeV (Curran et al.,
1991b). The C protein, however, is seen to be strongly
colocalised with the P protein and hence also with the N
and L proteins (Figs. 1g and 1h). No specific accumula-
tion of the C protein was seen in the nucleus.
Yeast two-hybrid screen of interactions of the RPV C
and V proteins with other rinderpest proteins
A series of plasmids were engineered as described
under Materials and Methods in which the GAL4 DNA
binding domain (pAS2) was fused with the L, N, P, V, C,
and V-specific ORFs and the GAL4 DNA activating do-
main (pACT2) was fused to the N, P, V, C, and V-specific
ORFs. The set of BD and AD vectors were transformed
into yeast and the anticipated protein expression con-
firmed by SDS–PAGE and Western blotting using anti-
FIG. 1. Immunofluorescence localisation of the core proteins of
rinderpest virus in infected cells. Vero cells were infected with RPV for
2 days before fixing and staining with various antibodies as described
under Materials and Methods. Top: labelling with rabbit antisera recog-
nising RPV N (a), RPV L (c), RPV V (e), and RPV C (g). Bottom, (b, d, f, and
h): labelling of the RPV-P protein in the same fields.bodies to the mid-fusion HA-tag present in the pAS2 and
pACT2 vectors (data not shown). Initially, all recombinantvectors were transformed individually into yeast Y190
cells and assayed for the ability to induce the expression
of b-galactosidase since some single recombinant plas-
ids could have the ability to generate reporter gene
xpression. b-galactosidase expression, obtained by re-
onstitution of GAL4 activity, was assayed qualitatively
uring mid-log phase using the substrate X-gal.
As shown in Table 1, RPV P protein, V protein, and the
-specific (Vs) domain of V, when fused to the binding
omain, activated transcription of the downstream b-ga-
actosidase reporter gene. Transcriptional activity in the
east two-hybrid system of the morbillivirus P protein has
een previously observed for RPV (Shaji and Shaila,
999), whilst the activity of the V protein might have been
ue to the sequence it shares with the P protein or to the
imilarity of the Vs domain with the GAL4 transcriptional
ctivating domain (Thomas et al., 1988). The ability of
PV P and V proteins fused to the GAL4 binding domain
o activate transcription of the downstream reporter
ene, in the absence of an activating domain fusion,
ould prevent detection of genuine interactions. Conse-
uently, these constructs could not be used to detect
rotein–protein interactions in this assay.
The remaining constructs, which did not autoactivate
eporter gene expression, were co-transformed in all
ombinations of binding and activating domains and
ssayed for b-galactosidase activity; the results are
shown in Table 2. Interactions were seen between N and
itself and P and L. These interactions were anticipated
since L and P are assumed to form part of the polymer-
ase complex and have been shown to interact in other
paramyxoviruses (Horikami et al., 1994; Parks, 1994;
Smallwood et al., 1994), and N–N interactions forming
nucleocapsid-like structures have also been shown for
other viruses (Buchholz et al., 1993; Fooks et al., 1993;
ishio et al., 2000). Interaction of the amino terminus of
TABLE 1
b-Galactosidase Expression Induced in Y190 Yeast by Individual
Recombinant Two-Hybrid Plasmids
BD-X fusions AD-X fusions
b-Galactosidase
expressiona
— pACT2-N 2
pAS2-N — 2
— pACT2-P 2
pAS2-P — 1
— pACT2-V 2
pAS2-V — 1
— pACT2-C 2
pAS2-C — 2
— pACT2-Vs 2
pAS2-Vs — 1
pAS2-L — 2a 2 indicates no b-galactosidase expressed; 1 indicates b-galacto-
sidase was expressed.
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196 SWEETMAN, MISKIN, AND BARONP, which is shared with the V protein, with unassembled
N protein has been observed in Rubulaviruses, Respiro-
iruses, and Morbilliviruses (Curran et al., 1995; Harty
nd Palese, 1995; Randall and Bermingham, 1996), and
e therefore anticipated observing N–P and N–V inter-
ctions. However, only the latter was observed (Table 2).
he P ORF within the AD–P construct used in these
tudies was sequenced and found to be correct (data not
hown). No interactions were seen between the carboxyl
erminus (Vs) of the V protein and N, C, or L.
Weak activation of the b-galactosidase reporter gene
as observed in the case of the combination of BD–N
nd AD–C fusion proteins (indicated by a 6) in which a
mall proportion of the transformed colony expressed
b-galactosidase. This may represent a weak or transient
interaction that requires further investigation. Both the V
and C proteins were seen to interact with the L protein;
because the Vs domain of V appeared not to interact with
the L, the common P/V sequence may be responsible for
the interaction of P and V with the L protein. The C
protein was seen to form a further interaction with itself.
Since this might indicate the formation of a discrete
oligomer, we further examined the size of the native RPV
C protein.
Migration of native rinderpest C protein within a
sucrose density gradient
To investigate the observed C–C protein interaction
shown in Table 2, cells were infected with either rinder-
TABLE 2
b-Galactosidase Expression Induced in Y190 Yeast after Transfor-
mation with Combinations of Binding Domain (BD) and Activation
Domain (AD) Fusions
BD-X fusions AD-X fusions
b-Galactosidase
expressiona
pAS2-N pACT2-N 1
pAS2-N pACT2-P 2
pAS2-N pACT2-V 1
pAS2-N pACT2-C 1/2
pAS2-N pACT2-Vs 2
pAS2-C pACT2-N 2
pAS2-C pACT2-P 2
pAS2-C pACT2-V 2
pAS2-C pACT2-C 1
pAS2-C pACT2-Vs 2
pAS2-L pACT2-N 2
pAS2-L pACT2-P 1
pAS2-L pACT2-V 1
pAS2-L pACT2-C 1
pAS2-L pACT2-Vs 2
a 2 indicates no b-galactosidase expressed; 1 indicates b-galacto-
sidase was expressed; 1/2 indicates weak or partial expression.pest virus or a recombinant adenovirus expressing the C
protein of rinderpest virus (AdC). Infected cells werelysed 3 days p.i., and the lysates centrifuged through
5–20% sucrose gradients. The position of the C protein
within the gradient was determined by Western blotting
of the total protein in each fraction. Parallel calibration
gradients were also prepared containing BSA, ovalbu-
min, and lysozyme. From the migration of these stan-
dards, monomeric C protein was expected around frac-
tion 8, dimer in fractions 5/6, and trimer in fractions 4/5
given its calculated molecular weight (19.9 kDa).
As shown in Figure 2, RPV C protein, when expressed
in the absence of other RPV proteins, is found both as the
monomeric protein, around fraction 8, and as a spectrum
of sizes throughout most of the gradient, particularly
toward the base, with the majority of the protein in the
bottom fractions. In lysates of RPV-infected cells, a sim-
ilar distribution is seen (Fig 2), except that the high-
molecular-weight form of C is now almost entirely in the
last fraction. We had previously found that inclusion of
high-salt concentrations (0.5 M NaCl) in the lysis buffer
improved the recovery of C protein from infected cells.
Analysis of lysates from either RPV- or AdC-infected cells
prepared using a high-salt lysis buffer showed a re-
distribution of C protein; although the C protein is still
found throughout the gradient, the majority is now seen
as monomeric C (Fig 2) whether the C protein was
expressed alone or in company with other RPV proteins.
Disruption of the C-protein association under high-salt
conditions indicates a possible ionic interaction. It is
clear from these data that the RPV C protein associates
in very high-molecular-weight forms and that these high-
molecular-weight forms do not require the presence of
other viral proteins. In addition, immunoprecipitation of
radiolabelled C protein from similar gradients failed to
show coprecipitation of any labeled cell protein (data not
shown). These findings support the observation of a C–C
interaction in the yeast two-hybrid system, while sug-
gesting that the C protein does not form discrete dimers,
trimers, or tetramers but rather a broad size range of
FIG. 2. Sucrose density gradient analysis of native RPV C protein.
B95a cells were infected with RPV, and 293 cells infected with AdC, for
2–3 days. Infected cells were lysed in buffers containing 100 mM NaCl
(RPV–NS, AdC–NS) or 500 mM NaCl (RPV–HiS, AdC–HiS), and lysates
centrifuged through 5–20% (w/v) sucrose gradients for 48 h. The gra-
dients were divided into 10 fractions, and the proteins in each fraction
were precipitated with TCA; the amount of C protein was determined by
SDS–PAGE and Western blotting using rabbit anti-RPV C protein.
197INTERACTIONS OF RINDERPEST VIRUS V AND C PROTEINSaggregates. The aggregation of C does appear to be
influenced by other RPV proteins since the distribution
near the bottom of the gradient is broader in the AdC-
derived samples than in those from RPV-infected cells.
Analysis of the interactions of RPV N, P, and L
proteins with the C or V proteins using fusions with
glutathione-S-transferase (GST)
To confirm the interactions between the RPV C and V
proteins and the N and L proteins, a second system was
devised to detect protein–protein interactions. In this
system, the ORFs of C and V were fused in frame to the
ORF of glutathione-S-transferase (GST), the whole fusion
being placed downstream of a T7 promoter. These fu-
sions were transiently expressed in eukaryotic cells
along with the L, N, P, or C proteins (from other T7
promoter constructs). A recombinant modified vaccinia
virus Ankara (MVA) (Sutter et al., 1995) was used as a
source of T7 RNA polymerase. The co-transfected cells
were radiolabelled with 35S and lysed. The GST fusion
was then extracted from the cell lysate using glutathio-
ne–Sepharose beads, and the bound proteins analyzed
by SDS–PAGE. Other viral or host cell proteins that in-
teracted with the fusion protein should be copurified on
the Sepharose beads and visualised on the gel. In our
experiments, lysates were clarified and split into two
equal fractions; the co-expressed rinderpest protein was
immunoprecipitated from one fraction, to confirm its ex-
pression, and the GST fusion was extracted from the
remaining fraction using glutathione–Sepharose. Note
that two of the antisera used, rabbit anti-C (MB37) and
rabbit anti-L (MB41) were raised against bacterially ex-
pressed GST fusion proteins and therefore also recog-
nise and immunoprecipitate GST and any GST fusion.
GST and the GST fusion proteins were expressed
efficiently from the T7 promoter in Vero cells and could
be bound to glutathione–Sepharose beads (Fig 3). None
of the RPV proteins bound to coexpressed GST (Fig 3a).
We were unable to determine by this assay whether
GST–C bound C protein since the C protein expressed
from pKSC was always found cleaved despite attempts
to prevent degradation during cell lysis using a wide
variety of protease inhibitors (data not shown), suggest-
ing that the C protein was being degraded intracellularly
before cell lysis. We did not see this cleavage in either
RPV-expressed C nor that expressed from AdC. In addi-
tion, the C ORF in the T7 expression plasmid was correct
since it was that used for constructing AdC; it is possible,
therefore, that this cleavage was due to a vaccinia-
encoded protease. The GST–C fusion itself appeared to
be more resistant to this protease, although a labeled
protein migrating only slightly slower than GST was al-
ways observed in GST–C-expressing cells, which may
have resulted from partial cleavage of the fusion protein.
As expected, since no interaction of V or C with P wasseen in the yeast two-hybrid system, neither GST-C nor
GST-V bound coexpressed P (Figs. 3b and 3c). Note that
the P protein was consistently found in two forms in
these experiments, corresponding in apparent size to the
phosphorylated and non-phosphorylated forms of the
protein. No N protein bound to either fusion protein,
although the N protein was clearly expressed along with
the respective fusion protein. However, both GST–V and
GST–C specifically bound the L protein, which was
FIG. 3. Coexpression of RPV N, P, or L proteins with GST or GST
fusions. GST (a), GST–C (b), or GST–V (c) (from pGST, pGST–C, and
pGST–V, respectively) were expressed with RPV N, P, or L (from pKS–N,
pKS–P, or pGEM–L, respectively) using the MVA-T7 transient expres-
sion system described under Materials and Methods. After metabolic
labelling of proteins with 35S, the cells were lysed and half of the lysate
incubated with glutathione–Sepharose (tracks “g”). The remainder was
immunoextracted (tracks “ip”) with rabbit anti-RPV C, which also recog-
nises GST (tracks “none”), rabbit anti-RPV N (tracks “pKS–N”), mouse
monoclonal anti RPV P (tracks pKS–P“), or rabbit anti-RPV L, which, like
the rabbit anti-C, recognises GST (tracks ”pGEM–L“). The immunopre-
cipitated or glutathione-bound proteins were analyzed by SDS–PAGE
and fluorography.brought down almost quantitatively.
To see if this interaction with the L protein could also
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with RPV and then transiently expressed GST, GST–C, or
GST–V as previously. Since it was possible that virus-
expressed C or V protein would compete with the re-
spective fusion protein, we also used mutant RPVs un-
able to express C (V1C2) or unable to express V (V2C1).
Since the vaccine strain of RPV, and especially these
mutants, does not grow to high titres, we were unable to
infect the cells with RPV at high m.o.i.’s. We therefore
transfected the cells 24 h p.i. with RPV and labeled 24 h
after that at which time most of the cells were showing
some signs of cytopathic effect. Under these conditions,
many of the cells will be both infected and transfected.
After labelling with 35S, GST or fusion protein was ex-
tracted as before and the samples analyzed on SDS–
PAGE gels (Fig 4). As can be seen, the L protein bound
to GST–C when expressed in RPV-infected cells, though
slightly more was bound if the RPV did not express C
itself (compare V1C1/GC with V1C2/GC). The L protein
was also bound by GST–V, although in this case the
binding was only detectable when RPV–V2C1 was used
Fig 4).
The C–L interaction was further analyzed in an attempt
o map which part of the C protein was binding to L.
equence alignment of the Morbillivirus C proteins re-
veals relatively low sequence conservation between vi-
ruses (see, for example, Fig 3b, Baron et al., 1993). A
higher degree of sequence conservation can be seen
toward the carboxyl terminus, in particular amino acids
103–120, which are almost completely conserved in all
morbilliviruses. We therefore produced three more GST
fusions (Fig 5a) containing (i) the carboxyl-terminal half of
C from the start of the conserved domain (pGEM-GST–
CND), (ii) the amino terminus of the C protein up to the
FIG. 4. Binding of RPV-expressed L protein to GST–C and GST–V.
Vero cells infected with RPV2 (Baron and Barrett, 1997) (V1C1), RPV C2
(V1C2) or RPV V2(V2C1) (Baron and Barrett, 2000) for 24 h were
infected with MVA-T7 and transfected with pGST (G), pGST–C (GC), or
pGST–V (GV). After a further 24 h, the cells were labeled with 35S, lysed
nd the lysates extracted with glutathione–Sepharose as described
nder Materials and Methods. Proteins bound to the glutathione were
nalyzed by SDS–PAGE and fluorography.conserved domain (pGEM-GST–C79D), and (iii) the
amino terminus of the C protein plus the conserveddomain (pGEM-GST–C44D). Co-expression of each of
these specific domains of the C protein with the L protein
demonstrated that all three had the ability to bind the L
protein (Fig. 5b).
DISCUSSION
A striking property of the genera of the subfamily
Paramyxovirinae is the production of multiple protein
products from the single P gene. In addition to the P
protein itself, which appears to function both as a com-
ponent of the viral RNA-dependent RNA polymerase and
as a cofactor in genome encapsidation (Hamaguchi et
al., 1983; Deshpande and Portner, 1985; Horikami et al.,
1992; Curran et al., 1995), viruses have evolved to pro-
duce one or two further proteins. The flexibility of the P
gene appears to be the result of a lack of selective
pressure on the sequence of large sections of the P
protein (Jordan et al., 2000), a finding that is in accord
with the observation that residues 145–324 of the SeV P
protein are not required for either mRNA transcription or
genome replication and that either of two regions (1–77
or 78–144), but not both, are required for mRNA synthesis
(Curran et al., 1994, 1995).
The functions of the V and C proteins expressed from
the P gene are still being elucidated. While the V proteins
of all these viruses follow a pattern of being the amino-
FIG. 5. Deletion analysis of L-binding domains of the C protein. (a)
Schematic illustration of the three deletion mutants of the RPV C protein
made as fusions to GST. The shaded box represents the highly con-
served region (amino acids 103–120) in morbillivirus C proteins. (b)
pGEM-L was transfected into MVA-T7-infected Vero cells with each of
the plasmids encoding a C deletion fusion to GST. The cells were
labeled with 35S, lysed and extracted with glutathione–Sepharose
(tracks “g”) or rabbit anti-RPV L (tracks “ip”) as described in Fig. 3.
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199INTERACTIONS OF RINDERPEST VIRUS V AND C PROTEINSterminal half of the viral P protein fused to a conserved
zinc-binding cysteine-rich domain, the situation with the
C proteins is more complex since the Rubulaviruses do
not express a C protein at all, and those of the other two
genera do not appear to share any sequence similarity.
Even V protein expression is not uniform since hPIV1 and
hPIV3 have, respectively, lost or no longer express the
V-specific reading frame (Matsuoka et al., 1991; Galinski
et al., 1992). Neither the C nor the V protein is essential
for virus replication since a number of recombinant
paramyxoviruses have been made in which expression
of V (Delenda et al., 1997; Kato et al., 1997a; Schneider et
al., 1997), C (Radecke and Billeter, 1996), or both (Baron
and Barrett, 2000) has been abrogated, and these vi-
ruses are viable in tissue culture, albeit to different ex-
tents.
We have used the yeast two-hybrid system as a means
of investigating possible protein–protein interactions en-
tered into by the RPV C and V proteins. Self-assembly of
expressed MeV (Fooks et al., 1993) or SeV (Buchholz et
al., 1993) nucleocapsid proteins suggested that we
should see an N–N interaction, and indeed we observed
this interaction in the case of the RPV protein. Interest-
ingly, another recent study of interactions of the RPV N
and P proteins failed to show an N–N interaction (Shaji
and Shaila, 1999) despite the N ORF used in that study
being obtained from the same N clone (pKS-N1, Baron
and Barrett, 1995) as the work presented here. On the
other hand, we failed to detect an N–P interaction de-
spite the previous observation of such an interaction
between RPV N and P (Shaji and Shaila, 1999) and MeV
N and P (Harty and Palese, 1995; Liston et al., 1995) using
two-hybrid systems and its observation in other related
viruses (Huber et al., 1991; Precious et al., 1995; Slack
and Easton, 1998). A number of studies have shown that
different domains of paramyxovirus P proteins interact
with monomeric and assembled N protein, that the inter-
action of P with monomeric N is a function of the com-
mon aminoterminal domain of P and V, and that V also
binds to the N protein (Ryan and Kingsbury, 1988; Ryan
and Portner, 1990; Huber et al., 1991; Harty and Palese,
1995; Precious et al., 1995; Horikami et al., 1996; Randall
and Bermingham, 1996; Watanabe et al., 1996). It is
thought that the P and V proteins may act as chaperons
in the assembly of nucleocapsids (Curran et al., 1995)
and/or regulate the switch from mRNA transcription to
antigenome transcription (Horikami et al., 1996). Interest-
ingly, we did observe the expected interaction between
RPV V and N proteins, showing that the amino-terminal
fusion of the AD to the P protein was not in itself suffi-
cient to block interaction with N. It may be that, in our
system, the P-specific part of the AD–P fusion folded in
such a way as to prevent access of N to the amino
terminus of P or to prevent access to the AD part of the
fusion by the cell-transcription machinery. The previous
studies with RPV and MeV proteins used alternative
g
aGAL4 expression vectors that may have proved more
conducive to detecting the N–P interaction.
We also observed an interaction between the L and
the P proteins; these proteins together form the viral
polymerase and have been shown to interact in SeV
(Smallwood et al., 1994), MeV (Horikami et al., 1994), and
SV5 (Parks, 1994). It is not clear from our studies whether
this interaction is primarily through the P-specific part of
the P protein or through the common P/V domain. We
found a previously unreported V–L interaction for RPV,
both in the yeast two-hybrid system and with co-transla-
tional expression of GST–V with pGEML. RPV V protein,
although distributed throughout the cytoplasm, is also
concentrated in cellular regions in which RPV L, N, and
P proteins colocalise as seen with immunofluorescence
(Fig. 1). Our studies in the yeast two-hybrid system did
not show any interaction between the L protein and the
carboxyl terminus (Vs) of V, indicating that the V–L inter-
action is due to the P/V domain. This suggests that the
observed L–P interaction in RPV is a function of the
amino terminus of the P protein. Studies in SeV, on the
other hand, showed that the entire amino terminal 324
amino acids of the P protein of that virus could be
deleted without abolishing binding to L and identified a
region in the carboxyl-terminus of P that is critical for
binding to L (Horikami et al., 1994). Although there is only
limited sequence similarity between the P proteins of the
different paramyxovirus genera, it must be considered
that RPV P–L interaction may be mediated by sites in
both the amino or carboxyl termini of the P protein. The
carboxyl-terminal Vs domain did not bind to any viral
proteins; this is in agreement with the finding that this
domain binds to a host cell protein, damaged DNA-
binding protein (Lin et al., 1998). The combination of
binding data with studies on recombinant paramyxovi-
ruses suggests that the two domains of V proteins have
quite different functions, with the common P/V domain
acting as a regulator of genome replication (Curran et al.,
991a; Tober et al., 1998; Baron and Barrett, 2000) and the
s domain being required for normal growth in the host
ell (Kato et al., 1997a,b; Valsamakis et al., 1998; Huang
t al., 2000).
We have identified a clear interaction between RPV C
nd L proteins, both by the yeast two-hybrid system and
sing co-translational expression of the GST–C fusion
ith pGEML. The interacting domain of the C protein was
nvestigated using amino and carboxyl-terminal dele-
ions spanning the conserved residues 102–124 (Fig. 5).
eleting the aminoterminal 86 amino acids of the C
rotein did not abrogate the binding to the L protein nor
id removal of 44 or 79 carboxyl-terminal amino acids,
he latter of which removed the conserved motif. The
inding that both amino and carboxyl-terminal halves of
he C protein can independently bind the L protein sug-
ests either that the L-binding domain in C lies in the 12
mino acid span (amino acids 87–98) that is the only
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200 SWEETMAN, MISKIN, AND BARONsegment of C common to all three constructs or that the
C–L interaction is mediated by at least two separate
contacts between these two proteins. Given the com-
plete lack of sequence conservation between morbillivi-
ruses in C87–C98, the former possibility is less likely.
Further work is required to determine whether the two
halves of C interact with the same domain on the L
protein. An interaction between the L and C proteins has
also been reported for SeV (Horikami et al., 1997), sug-
gesting that the modulation of viral transcription in this
virus by its C proteins is mediated by a direct effect on
the polymerase. It is interesting to note that the C pro-
teins of both RPV and SeV have no sequence similarity,
yet both bind to the same viral protein. Recombinant RPV
lacking C protein shows reduced viral RNA synthesis
(Baron and Barrett, 2000) as is also the case for SeV in
which expression of both C9 and C is prevented (Kurotani
et al., 1998). Further work is required to determine the
exact role of RPV C in viral transcription. Given the stable
interaction of C and L in RPV, however, it seems likely
that the C protein will be found in virions, though only at
the low level at which L is found.
We observed weak stimulation of b-galactosidase syn-
hesis is yeast transformed with pACT2-C and pAS2-N,
hough not with the reverse set (pACT2-N plus pAS2-C).
his may indicate a weak or transient interaction be-
ween the N and C proteins. Transient interactions in the
wo-hybrid system might allow short bursts of expression
f the reporter gene, and b-galactosidase is a relatively
table protein that would accumulate over time. In the
olid phase assay used in our study, the transformed
east grow to sizable colonies, allowing time for accu-
ulation of b-galactosidase. If the N–C interaction in
RPV is a weak interaction, this would explain why it was
detected in the yeast and not with the GST–C fusion,
which requires the protein–protein interaction to be
strong enough to be maintained through pelleting of the
Sepharose beads and multiple rounds of washing. This
may also explain our failure to show interaction of GST–V
with N in the eukaryotic expression system, despite clear
interaction of these two proteins in the two-hybrid assay.
The yeast two-hybrid system did reveal a previously
unreported interaction between the C protein and itself.
Due to the susceptible nature of the C protein within
vaccinia virus-infected cells, co-translational expression
of GST–C with RPV C could not be used to confirm this
interaction. When native C protein, synthesised within
RPV infected cells, was analyzed on sucrose density
gradients, the majority of C protein was shown to accu-
mulate at the bottom of the gradient as a protein aggre-
gate of high molecular mass, which may have been due
to association of the C protein with viral nucleocapsids
through the L protein. However, expressing the C protein
in the absence of other viral proteins using a recombi-
nant adenovirus showed that the protein was again
present as very high-molecular-weight aggregates that
w
Ppelleted in the sucrose gradient. These data suggest that
the RPV C protein does bind to itself, and the aggregation
of C protein was found to be disrupted in lysates gener-
ated using high-salt buffers (Fig. 2), indicating that the
C–C interaction is primarily ionic. It is not yet clear
whether the C–C interactions form in addition to C–L or
only when the L protein is not present. Further investi-
gation is required to determine whether the C–C inter-
action is of any biological significance.
The data presented here strongly suggest that the RPV
C and V proteins interact directly with the viral polymer-
ase (L) protein. In addition, the V protein was found, as
with the V proteins of other paramyxoviruses, to bind to
the N protein and the C protein to self-associate. A
previous study using the C and V proteins of the closely
related MeV (Liston et al., 1995) failed to show interaction
f these proteins with any other viral protein. However,
hat study utilised bacterially expressed GST fusions that
ere used to bind virally expressed proteins in vitro; we
ound that co-expression of GST–C with L was required
or efficient binding of L (data not shown), similar to the
indings with SeV proteins (Horikami et al., 1997). We
lso found that GST–C expressed in RPV-infected cells
ould bind to and co-precipitate L protein, but detection
f GST–V binding to virally expressed L protein required
mutant virus that does not express its own V protein. In
oth cases, the GST fusion protein was present in ex-
ess over the viral protein. These observations suggest
hat the C–L interaction is not inhibited by the aminoter-
inal fusion, in accord with the observation that C–L
nteraction can be mediated by the carboxyl-terminal half
f C alone. The V–L interaction, on the other hand, is
nhibited by an aminoterminal fusion to the V protein
ince this fusion competes poorly with the native V pro-
ein.
MATERIALS AND METHODS
ells, viruses, and antibodies
B95a, 293, and Vero cells were maintained as previ-
usly described (Baron and Barrett, 1997). A recombinant
ersion (Baron and Barrett, 1997) of the RPV vaccine
train RBOK (Plowright and Ferris, 1962) was used
hroughout. Mutant versions of this strain of RPV that lack
xpression of the V or C protein have been described
reviously (Baron and Barrett, 2000). Rabbit polyclonal
ntisera recognising RPV N and C proteins have been
escribed previously (Baron et al., 1999; Baron and Bar-
ett, 2000). Polyclonal antiserum MB41 recognising the
PV L protein was raised against bacterially expressed
usion protein containing glutathione-S-transferase (GST)
used to the carboxyl-terminal third of the L protein in the
ector pGEX3c (Amersham Pharmacia Biotech). Mouse
onoclonal antibody 2-1 recognising the RPV P protein
as the kind gift of M. Sugiyama, Dept. of Veterinary
ublic Health, Faculty of Agriculture, Gifu University, Gifu
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201INTERACTIONS OF RINDERPEST VIRUS V AND C PROTEINS501-11, Japan. Immunofluorescence microscopy of RPV-
infected Vero cells was performed as previously de-
scribed (Baron et al., 1999). Briefly, Vero cells were in-
fected with RPV at a low m.o.i. for 36 h, fixed in 3%
paraformaldehyde, and permeabilised in 0.5% (v/v) Triton
X-100 before incubating with the indicated primary anti-
bodies for 30–60 min. The cells were washed four times,
incubated with the secondary (fluorescent) antibodies for
a further 30–60 min, washed again, and mounted in
Mowiol (Calbiochem).
Molecular biology and assays
Unless otherwise indicated, all molecular biology was
performed using standard techniques. Plasmids were
cloned in Escherichia coli JM109 or DH5a and purified
sing CsCl gradients. To make a recombinant adenovi-
us expressing the C protein, the plasmid pKS–P was
utated using the unique site elimination mutagenesis
ystem (Deng and Nickoloff, 1992) to eliminate the P/V
nitiation codon, giving rise to plasmid pKSC. The result-
nt mutated P gene was excised from the plasmid with
otI, made blunt-ended with T4 polymerase, and ligated
nto similarly blunt-ended adenovirus transfer vector
AH1 (Galbraith et al., 1998). Recombinant adenovirus
as made as described (Galbraith et al., 1998).
Binding domain and activating domain plasmids for
he yeast two-hybrid system were generated using pAS2
nd pACT2, respectively (gifts from Dr. S. J. Elledge,
epartment of Biochemistry, Bayor College of Medicine,
ouston, TX). Protein ORFs for the RPV P and C proteins
ere PCR amplified from pKSP (Baron and Barrett, 1997)
sing primers engineered to contain restriction endonu-
lease sites compatible with the NcoI and BamHI sites
ithin the multiple cloning sites of pAS2 and pACT2. ORFs
ncoding the V protein and carboxyl-terminus of V (Vs) were
mplified from a similar cDNA clone derived from a V-type
RNA (pKSV). All PCR was performed using the proof-
eading polymerase Pfu (Stratagene) as previously de-
cribed (Baron et al., 1999). The forward primer used to
mplify P and V was dGGATCCCCATGGCAGAGGAG-
AAGCC (NcoI site in italics), the forward primer used to
mplify the carboxyl-terminus of V (Vs) was dGGATC-
CCATGGGGCACAGACGTGAAAT, the reverse primer for P
as dGCAGATCTCTAGTTCTTTAGAATT (BglII site in ital-
cs), and the reverse primer for both V and Vs was dC-
GAGGATCCATGTTACTCTGGGATAT (BamHI site in ital-
cs). The C ORF was amplified using the forward primer,
GGATCCCCATGGGGTCAACAAAGGCCTGGAA (CPROTF)
nd the reverse primer dCCGAGGATCCCTACTGTTTCAA-
ATCGGA (CPROTR). The RPV N ORF was PCR amplified
rom pKSN-1 (Baron and Barrett, 1997) using the forward
rimer dGGATCCCCATGGCTTCTCTCTTGAA and the re-
erse primer dCCGAGGATCCTCAGTTGAGAATATCCT. Li-
ations of the suitably digested, PCR amplified ORFs with
he NcoI/BamHI-digested vectors created pAS2–N,
p
GAS2–P, pAS2–V, pAS2–C, pAS2–Vs, pACT2–N, pACT2–P,
ACT2–V, pACT2–C, and pACT2–Vs. Correct fusion of the
PV ORFs to the GAL4-derived sequences in pAS2 and
ACT2 were confirmed by restriction digestion and se-
uencing. Since the RPV L ORF begins naturally with an
coI site, it was cloned directly into the yeast vectors in
hree-fragment ligations. The NcoI–SphI and SphI–SalI frag-
ents from the RBOK L gene in pMDBRPV (Baron and
arrett, 1997) were ligated with pAS2 that had been di-
ested with NcoI and SalI or pACT2 that had been digested
with NcoI and XhoI.
Fusions were generated between glutathione-S-
transferase (GST) and RPV V protein, C protein, and
three sections of the C protein. The GST ORF was PCR
amplified from pGEX-2T (Amersham Pharmacia Bio-
tech) using forward primer dCTCCCAGAATTCACCAT-
GTCCCCTATACTAGGTT (incorporating an EcoRI site)
and one of two reverse primers; dGACAGACCAT-
GGGGATCCACGCGGAACCA (incorporating a NcoI
ite) was used for fusion to RPV-derived ORFs, while
GACACAAGATCTTTATTATCCACGCGGAACCAGAT (in-
orporating a BglII site and two stop codons downstream
f the GST ORF) was used for expressing the GST pro-
ein on its own (the restriction sites are shown in italics
nd the stop codons are in bold text). An expression
ector, pGEM7Zf (Promega), that contains the T7 RNA
olymerase promoter was restriction endonuclease di-
ested with EcoRI and BamHI. Ligation of pGEM7Zf with
he GST PCR product generated using the stop-codon
nclusive reverse primer created pGST. RPV V or C ORFs
ere excised from the pAS2 constructs with NcoI and
amHI, and three-fragment ligations with pGEM7ZF, PCR
mplified GST, and the appropriate RPV-derived ORF
ave rise to pGST–C and pGST–V. Aminoterminal and
arboxyl-terminal deletions of the C protein were gener-
ted by PCR amplification of regions of the C ORF using
orward primers incorporating an NcoI site and reverse
rimers containing a BamHI site. In this manner, the
minoterminal 86 amino acids of the C protein were
eleted using the forward primer dAGATCGCCATGGAG-
ATTCATTGGTGACT in conjunction with CPROTR
above) to give pGST-CND. carboxyl-terminal deletions of
4 and 79 amino acids were generated using CPROTF in
onjunction with the reverse primer, dCCTGGATC-
CTACTTCGACACCATCATCA, giving rise to pGST-C44D
r dCCAAGGATCCCTACTTCGACACCATCATCAG, giving
ise to pGST-C79D.
ransformation of plasmids into yeast
Saccharomyces cerevisiae Y190 (MATa GAL4 gal80 his3
rpl-901 ade2-101 ura3-52 leu2-3, 21121URA::GAL(UAS)3
IS3 cyhr) were transformed with activating domain
pACT2) and binding domain (pAS2) plasmids fused to RPV
rotein ORFs by the lithium acetate method (Schiestl and
ietz, 1989). Transformed yeast were plated on 1.5% (w/v)
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202 SWEETMAN, MISKIN, AND BARONagar plates containing synthetic-defined medium (SD) [2%
w/v dextrose, 0.168% w/v Yeast Nitrogen Base without
amino acids (Life Technologies), 30 mg/ml isoleucine, 150
mg/ml valine, 20 mg/ml adenine hemisulphate salt, 20
mg/ml arginine, 30 mg/ml lysine-HCl, 20 mg/ml methionine,
50 mg/ml phenylalanine, 200 mg/ml threonine, 30 mg/ml
yrosine, and 20 mg/ml histidine] with or without selection
amino acids (100 mg/ml leucine and 20 mg/ml tryptophan)
s required. Selection plates were incubated for 3–4 days
t 30°C. pACT2 transformants were grown on SD agar
acking leucine (SDL2) and pAS2 transformants on SD agar
acking tryptophan (SDT2). Resultant colonies were further
creened to verify correct plasmid insertion by double plat-
ng onto both SDT2 and SDL2. Double transformants were
elected on plates lacking both amino acids. Expression of
b-galactosidase was assayed by adsorbing transformed
yeast colonies onto Hybond-C extra nitrocellulose mem-
branes (Amersham) and placing the filters, colony side up,
into liquid nitrogen for 30 s. The frozen membrane was
allowed to thaw on 3MM (Whatmann) filter paper pre-
soaked in developing solution [98.74% v/v Z-buffer (60 mM
Na2HPO4, 39.7 mM NaH2PO4, 10 mM KCl, 1.014 M MgSO4),
0.27% v/v 2-mercaptoethanol, 0.99% v/v 100 mg/ml X-gal],
and incubated at 30°C for 0.5–4 h for colour to develop.
Sucrose density gradient analysis
Viral-infected cell lysates for sucrose gradient analysis
were obtained from B95a cells infected with RBOK RPV
at an m.o.i. of 0.1 or 293 cells infected with a recombinant
adenovirus expressing the C protein of RPV (AdC) at an
m.o.i. of 10. Infected cells in 35-mm dishes were lysed
using 500 ml of a normal salt lysis buffer [50 mM Tris–Cl
H 7.5, 100 mM NaCl, 2 mM EDTA, 1% (v/v) Nonidet-P40,
.5 mM iodoacetamide, 0.5 mM phenylmethylsulfonyl
luoride, and 100 ng/ml each of leupeptin, pepstatin,
ntipain and chymotrypsin] or a high-salt lysis buffer (as
ormal salt buffer, but with 500 mM NaCl). Lysates (200
ml) were subjected to centrifugation through 5–20% su-
crose density gradients as previously described (Baron
and Forsell, 1991). Gradients were unloaded from the
bottom in 10–12 approximately equal fractions, and the
protein in each fraction precipitated by making 10% with
trichloroacetic acid (TCA) and incubating on ice for 10
min. After centrifugation at 12,000 rpm in a microfuge, the
pellets were washed in acidified acetone (95% acetone,
0.1M HCl), dried, and redissolved in SDS–PAGE sample
buffer (Baron and Forsell, 1991). Samples were analyzed
by SDS–PAGE (Laemmli, 1970) and transferred to Hy-
bond-C (Amersham, U.K.) (Weir et al., 1984). Filters were
blocked with 10% (v/v) goat serum, 5% (w/v) Marvel non-
fat dried milk, and 2% (v/v) Tween 20 in 20 mM Tris, pH
7.5, and 150 mM NaCl (TBS), washed with 0.1% Tween 20,
and incubated with antibody overnight at 4°C or for 1 h
at room temperature. After washing, the filters were in-
cubated with horseradish peroxidase-conjugated goatanti-rabbit IgG (Sigma) for 1 h at room temperature,
washed again, and developed using SuperSignal
(Pierce) according to the manufacturer’s instructions.
Expression of GST fusions and viral proteins in
eukaryotic cells
Vero cells in 35-mm dishes were infected with MVA-T7
(Sutter et al., 1995) at an m.o.i. of ;0.1 for ;30 min, then
transfected with plasmids expressing RPV proteins fused
to glutathione-S-transferase (GST) with or without other
RPV-protein-expressing plasmids using Transfast (Pro-
mega) as described by the manufacturer and as previ-
ously published (Baron and Barrett, 2000). Where indi-
cated, cells were infected with RPV or mutant RPVs at a
m.o.i. of ;0.1 24 h prior to transfection. Cells were radio-
labelled using 35S-Promix (Amersham Pharmacia Bio-
ech.) 18–24 h posttransfection. Radio-labelling and im-
unoprecipitation were performed as previously de-
cribed (Baron and Garoff, 1990; Baron and Barrett,
000), except that the cells were lysed in the normal salt
ysis buffer described above. Half of each lysate was
mmunoextracted with an appropriate antibody, while
ST fusion proteins in the other half were collected on
lutathione–Sepharose (Amersham Pharmacia Biotech.)
y mixing at 4°C for 1 h. Glutathione–Sepharose beads
ere washed twice in 50 mM Tris/Cl, pH 7.5, 100 mM
aCl, 0.1% (v/v) Nonidet-P40 and twice in 10 mM Tris–Cl,
H 7.5, before eluting bound proteins in SDS–PAGE sam-
le buffer. Proteins were separated by SDS–PAGE and
etected by fluorography using salicylic acid (Chamber-
ain, 1979) .
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